cancergrace"Be here now, in the moment." Terri Conneran
Thank you for this amazing presentation!
#LungCancer #PatientAdvocate #KRAS #LungCancerSurvivor #TargetedTherapies #GRACE #KRASKickers
Now presenting Dr. Isabel Preeshagul: "ALK, ROS1 and RET Mutations".
Join us at https://give.cancergrace.org/event/lung-cancer-targeted-therapies-onctalk-2026/e759491
Q&A session with Drs. @LudaBazhenovaMD, Christina Baik, and @TejasPatilMD.
"How do you describe the 'quality of life' metric for targeted therapy?"
#LungCancer #EGFR #TP53 #RB1 #BRAF #NSCLC #SCLC #TargetedTherapies #LungCancerInformation
Do you want to learn more about #BRAF?
Join us now at our Lung Cancer Targeted Therapies OncTalk!
#LungCancer #TargetedTherapies #V600E #NSCLC #GRACE #LungCancerInformation
Why is it important to know the #KRAS subtype of a patient with #LungCancer?
Dr. Christina Baik explains everything you need to know about KRAS, BRAF, and more in our Lung Cancer Targeted Therapies OncTalk.
Don’t miss it!
Register here: https://give.cancergrace.org/event/lung-cancer-targeted-therapies-onctalk-2026/e759491
Now presenting Dr. Christina Baik:
"KRAS and BRAF mutated NSCLC".
"Any drug that targets #EGFR will, to some degree, have these #sideeffects." - Dr. Tejas Patil
We are back!
Now presenting: @TejasPatilMD. "We have come a long way. What the Lung Cancer Community Needs to Know about EGFR and HER2 Mutations."
Join us now!
https://give.cancergrace.org/event/lung-cancer-targeted-therapies-onctalk-2026/e759491
#LungCancer #TargetedTherapies #LungCancerInformation #GRACE
We’re on a 30-minute break—please stay tuned!
Dr. @SamtaniSuraj presenting: Cancer Cachexia, Key Takeaways.
- Cachexia is common, progressive, and clinically relevant.
- Early recognition is essential.
- The precachexia stage is the window of opportunity.
- Optimal strategies for treating cancer cachexia: major unmet need in oncology care.
#LungCancer #TargetedTherapiesOncTalk #LungCancerInformation #cachexia